BAM
DGX icon

Baldrige Asset Management’s Quest Diagnostics DGX Stock Holding History

Baldrige Asset Management’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		$0 Buy
+2
New +$286 ﹤0.01% 412

Other funds holding DGX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Baldrige Asset Management's DGX Position: Q1 2023 in Review

Baldrige Asset Management opened a new position in Quest Diagnostics (DGX) in Q1 2023: 2 shares worth $0. The stake represents ﹤0.01% of the portfolio and ranks #412 among its holdings.

834 funds tracked by Wall St. Rank hold DGX as of Q1 2023.

  • Baldrige Asset Management held 2 shares of Quest Diagnostics worth $0 as of Q1 2023.
  • Quest Diagnostics was a new Baldrige Asset Management position in Q1 2023.
  • Quest Diagnostics made up ﹤0.01% of Baldrige Asset Management's portfolio in Q1 2023, its #412 holding.
  • 834 funds tracked by Wall St. Rank held Quest Diagnostics as of Q1 2023.

Based on Baldrige Asset Management's 13F filing for Q1 2023, filed 17 Apr 2023.